ZENOTECH LABORATORIES
|
|
BOM : 532039     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap] Debt : Average |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Dec 05,2024 |
Price(EOD): ₹ 76.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 464.21 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
ZENOTECH LABORATORIES | -1.1% | -9.9% | 16.2% |
SUN PHARMACEUTICAL INDUSTRIES | 3.7% | -3.2% | 46.6% |
CIPLA | 0.6% | -3.7% | 26.7% |
DR REDDYS LABORATORIES | 1.9% | -3.4% | 5.8% |
ZYDUS LIFESCIENCES | 2.3% | -3.4% | 54% |
DIVIS LABORATORIES | 5.1% | 6.1% | 64% |
MANKIND PHARMA | 1.3% | -3.5% | 35.8% |
TORRENT PHARMACEUTICALS | 4.6% | 4.4% | 58% |
LUPIN | 5.1% | -4.4% | 62.5% |
FUNDAMENTAL ANALYSIS OF ZENOTECH LABORATORIES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF ZENOTECH LABORATORIES
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
69.75
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 6.66 Cr
[Latest Qtr - Sep2024 - Standalone Results ] 5.13
P/B Calculated based on Book Value of Rs 90.54 Cr
[Latest Year - Mar2024 - Standalone Results ] 11.69
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
29% -44% -49% |
SHARE PRICE MOMENTUM OF ZENOTECH LABORATORIES
ZENOTECH LABORATORIES vs SENSEX
DEBT OF ZENOTECH LABORATORIES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0 0 0.08 0.03 |
- - - - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF ZENOTECH LABORATORIES
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF ZENOTECH LABORATORIES
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-1.5% -30.01% 14.91% 4.5% |
-15.3% -56.37% -39.67% -52.42% |
QtrlyTrend |
-4 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
ZENOTECH LABORATORIES related INDICES
You may also like the below Video Courses
FAQ about ZENOTECH LABORATORIES
Is ZENOTECH LABORATORIES good for long term investment?
As on Dec 05,2024, the Fundamentals of ZENOTECH LABORATORIES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of ZENOTECH LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is ZENOTECH LABORATORIES UnderValued or OverValued?
As on Dec 05,2024, ZENOTECH LABORATORIES is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of ZENOTECH LABORATORIES ?
As on Dec 05,2024, the Intrinsic Value of ZENOTECH LABORATORIES is Rs. 136.67 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 58.91
Fair Value [Median EV / Sales Model] : Rs. 136.67
Fair Value [Median Price / Sales Model] : Rs. 147.91
Estimated Median Fair Value of ZENOTECH LABORATORIES : Rs. 136.67
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.